Skip to main content
IMNN
NASDAQ Life Sciences

Imunon Appoints Former CFO Jeffrey Church as Interim CFO Following Kimberly Graper's Resignation

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$3.88
Mkt Cap
$13.329M
52W Low
$2.99
52W High
$41.217
52W Position info
30% above low
Off High info
91% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

IMNN sits 30% above its 52-week low of $2.99.

Summary

Imunon, Inc. announced the resignation of its interim Chief Financial Officer, Kimberly Graper, and the immediate appointment of former CFO Jeffrey Church to the interim role, ensuring continuity in financial leadership.


Key Events · Executive and Board Changes · IMNN

  • Interim CFO Resignation

    Kimberly Graper resigned from her role as interim Chief Financial Officer, effective January 14, 2026, to pursue another career opportunity. The company stated her departure was without any disagreements with management.

  • Interim CFO Appointment

    Jeffrey Church, the company's former Executive Vice President, Chief Financial Officer, and Corporate Secretary, was appointed as interim Chief Financial Officer, effective January 14, 2026. Mr. Church had been in a consulting role since his retirement in May 2024.

  • Consulting Agreement Amended

    Mr. Church's consulting agreement was amended to provide a monthly retainer of $30,000, plus an additional $250 for each hour of services performed in excess of 40 hours per month during an extended consulting period.


Analysis · IMNN · Life Sciences

Imunon, a micro-cap company, announced a change in its interim Chief Financial Officer role. While the departure of Kimberly Graper, even for another opportunity, introduces some uncertainty, the immediate appointment of Jeffrey Church, a former Executive VP and CFO of the company, provides crucial continuity. Mr. Church's extensive prior experience with Imunon and other life science companies is a positive factor, mitigating the potential disruption of an executive transition. The compensation structure for Mr. Church reflects the importance of this role for the company.

At the time of this filing, IMNN was trading at $3.88 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13.3M. The 52-week trading range was $2.99 to $41.22. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IMNN - Latest Insights

IMNN
Jul 21, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.81
Real-time Price: $1.54 info
Change: -$0.2745 (-15%) info
Market Cap: $6.345M info
IMNN
Jun 30, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.78
Real-time Price: $1.54 info
Change: -$0.2445 (-14%) info
Market Cap: $6.345M info
IMNN
Jun 16, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.89
Real-time Price: $1.54 info
Change: -$0.3545 (-19%) info
Market Cap: $6.345M info
IMNN
Jun 04, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.16
Real-time Price: $1.54 info
Change: -$0.6245 (-29%) info
Market Cap: $6.345M info
IMNN
May 12, 2026, 8:45 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.86
Real-time Price: $1.54 info
Change: -$1.32 (-46%) info
Market Cap: $6.345M info